Bone marrow biopsy may soon be a thing of the past for myeloma patients
NCT ID NCT05625971
First seen Jan 05, 2026 · Last updated May 20, 2026 · Updated 22 times
Summary
This study looked at whether a simple blood test and a whole-body MRI scan can accurately detect leftover cancer cells (minimal residual disease) in people with multiple myeloma. The goal is to see if these non-invasive methods could replace the standard bone marrow biopsy, which is more painful and invasive. The study included 36 adults with newly diagnosed or previously treated myeloma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
New York Presbyterian Hospital/Columbia University Irving Medical Center
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.